investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Wei Gu

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Wei Dai

New York University

New York, United States

Ning Kon

Columbia University

New York, United States

Wei Gu

Columbia University

New York, United States

Related projects

Sarah A Holstein

Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Robert J Coffey

Role of EGFR Ligand-Containing Exosomes in Colorectal Cancer

Colorectum

Valen Earl Johnson

Consistent Model Selection in the p>>n Setting

Colorectum

Dieter Haemmerich

In vivo Derived in Silico Model for DDS Optimization

Colorectum

Vern L. Schramm

Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer

Colorectum

Xuefang Cao

Targeting Granzyme B to Separate GVH from GVL Responses

Non-Hodgkin lymphoma

Pak Cho

Physiological role of the TNKS-PI31 dependent proteasome regulation

Colorectum

John Jessup

Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells

Colorectum

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma

Pathology